(Amendment No. 1)
PROXY
STATEMENT
The special meeting (the “special meeting”)
of stockholders of Concord Acquisition Corp (“Concord,” “Company,” “we,” “us” or “our”),
a Delaware corporation, will be held on [●], 2022 at 11:00 a.m., local time, at the offices of Greenberg Traurig, LLP, located at
1750 Tysons Boulevard, Suite 1000, McLean, Virginia 22102 to consider and vote upon the following proposals:
|
● |
a proposal to amend (the “Charter Amendment”) Concord’s
amended and restated certificate of incorporation (the “charter”) to extend the date by which Concord has to consummate a
business combination (the “Extension”) from December 10, 2022 to January 31, 2023 (the “Extended Date”); and |
|
● |
a proposal to direct (the “Adjournment Proposal”) the chairman of the special meeting to adjourn the special meeting to a later date or dates, if necessary, to permit further solicitation and vote of proxies if, based upon the tabulated vote at the time of the special meeting, there are not sufficient votes to approve the foregoing proposal. |
The Charter Amendment is essential to the implementation
of the plan of the board of directors (the “Board”) to extend the date that Concord has to complete a business combination.
The purpose of the Charter Amendment is to allow Concord more time to complete its proposed business combination (the “Transaction”)
pursuant to the Transaction Agreement, dated as of February 16, 2022, by and among Concord, Circle Internet Financial Limited, a private
company limited by shares incorporated in Ireland (“Circle”), Circle Internet Finance Public Limited Company (f/k/a Circle
Acquisition Public Limited Company), a public company limited by shares incorporated in Ireland (“Topco”) and Topco (Ireland)
Merger Sub, Inc., a Delaware corporation (“Merger Sub”). Concord’s initial public offering (“IPO”) prospectus
and charter provide that Concord had until June 10, 2022 to consummate an initial business combination (or December 10, 2022 if Concord
extended the period of time to consummate an initial business combination, subject to Concord Sponsor Group LLC (the “sponsor”)
depositing additional funds into the trust account maintained by Continental Stock Transfer & Trust Company, acting as trustee (the
“trust account”). On June 7, 2022, Circle deposited $2,760,000 into the trust account (the “Extension Payment”),
which enabled Concord to extend the period of time it has to consummate its initial business combination from June 10, 2022 to December
10, 2022. While we have entered into the Transaction Agreement, Concord’s board of directors (the “Board”) currently
believes that there will not be sufficient time before December 10, 2022 to hold a special meeting to vote for stockholder approval of
the Transaction and consummate the Transaction. Accordingly, the Board believes that in order to be able to consummate the Transaction,
we will need to obtain the Extension. Therefore, the Board has determined that it is in the best interests of our stockholders to extend
the date that Concord has to consummate a business combination to the Extended Date so that our stockholders have the opportunity to participate
in this investment.
The affirmative vote of at least 65% of the outstanding shares of our
common stock is required to approve the Charter Amendment. Approval of the proposal to direct the chairman of the special meeting to adjourn
the special meeting requires the affirmative vote of a majority of the votes cast by the stockholders present in person or by proxy at
the special meeting. Notwithstanding stockholder approval of the Charter Amendment proposal, our Board will retain the right to abandon
and not implement the Charter Amendment at any time without any further action by our stockholders.
Holders (“public stockholders”) of
shares of Concord’s common stock (“public shares”) sold in the IPO may elect to redeem their shares for their pro
rata portion of the funds available in the trust account in connection with the Charter Amendment (the “Election”) regardless
of whether such public stockholders vote “FOR” or “AGAINST” the Charter Amendment and an Election can also be
made by public stockholders who do not vote, or do not instruct their broker or bank how to vote, at the special meeting. Public stockholders
may make an Election regardless of whether such public stockholders were holders as of the record date. However, regardless of whether
public stockholders vote “FOR” or “AGAINST” the Charter Amendment, or do not vote, or do not instruct their broker
or bank how to vote, at the special meeting, if the Charter Amendment is approved by the requisite vote of stockholders (and not abandoned),
the remaining public stockholders will retain their right to redeem their public shares for their pro rata portion of the funds
available in the trust account upon consummation of the business combination when it is submitted to the stockholders.
Any withdrawal of funds from the trust account
in connection with the Election will reduce the amount held in the trust account following the redemption, and the amount remaining in
the trust account may be significantly reduced from the approximately $279,177,550 that was in the trust account as of June 30, 2022.
In such event, Concord may need to obtain additional funds to complete a business combination and there can be no assurance that such
funds will be available on terms acceptable to the parties or at all.
If the Charter Amendment is not approved and we
do not consummate a business combination by December 10, 2022, as contemplated by our IPO prospectus and in accordance with our charter,
or if the Charter Amendment is not approved and we do not consummate a business combination by December 10, 2022, we will (i) cease
all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but no more than ten business days thereafter
subject to lawfully available funds therefor, redeem 100% of the issued and outstanding shares of Class A common stock issued in our IPO
(the “public shares”), at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the trust account,
including interest (which interest shall be net of taxes payable, and less up to $100,000 of interest to pay dissolution expenses), divided
by the number of then outstanding public shares, which redemption will completely extinguish rights of the holders of the public shares
(the “public stockholders”), as stockholders (including the right to receive further liquidating distributions, if any), subject
to applicable law, and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the remaining stockholders
and the Board in accordance with applicable law, liquidate and dissolve, subject in each case to our obligations under Delaware law to
provide for claims of creditors and the requirements of other applicable law.
Prior to the IPO, Concord’s initial stockholders
waived their rights to participate in any liquidation distribution with respect to their shares of Class B common stock, par value $0.0001
per share, which were acquired by them prior to the IPO (the “founder shares”). As a consequence of such waivers, a liquidating
distribution will be made only with respect to the public shares. There will be no distribution from the trust account with respect to
Concord’s warrants, which will expire worthless in the event we wind up.
To protect amounts held in the trust account,
our sponsor has agreed that it will be liable to us if and to the extent any claims by a third party for services rendered or products
sold to us, or a prospective target business with which we have discussed entering into a transaction agreement, reduce the amount of
funds in the trust account to below: (1) $10.00 per public share; or (2) such lesser amount per public share held in the trust account
as of the date of the liquidation of the trust account due to reductions in the value of the trust assets, in each case net of the amount
of interest which may be withdrawn to pay taxes, except as to any claims by a third party who executed a waiver of any and all rights
to seek access to the trust account and except as to any claims under our indemnity of the underwriters of our IPO against certain liabilities,
including liabilities under the Securities Act of 1933, as amended (the “Securities Act”). Moreover, in the event that an
executed waiver is deemed to be unenforceable against a third party, our sponsor will not be responsible to the extent of any liability
for such third-party claims. We have not independently verified whether our sponsor, has sufficient funds to satisfy its indemnity obligations
and believe that our sponsor’s only assets are securities of Concord and, therefore, our sponsor may not be able to satisfy those
obligations. We have not asked our sponsor to reserve for such obligations. As a result, if we liquidate, the per-share distribution
from the trust account could be less than $10.00 due to claims or potential claims of creditors. We will distribute to all of our public
stockholders, in proportion to their respective equity interests, an aggregate amount then on deposit in the trust account, including
any interest earned on the funds held in the trust account net of interest that may be used by us to pay our taxes payable.
Under the Delaware General Corporation Law (the
“DGCL”), stockholders may be held liable for claims by third parties against a corporation to the extent of distributions
received by them in a dissolution. The pro rata portion of our trust account distributed to our public stockholders upon the redemption
of our Public Shares in the event we do not complete our initial business combination within the required time period may be considered
a liquidating distribution under Delaware law. If the corporation complies with certain procedures set forth in Section 280 of the DGCL
intended to ensure that it makes reasonable provision for all claims against it, including a 60-day notice period during which any third-party
claims can be brought against the corporation, a 90-day period during which the corporation may reject any claims brought, and an additional
150-day waiting period before any liquidating distributions are made to stockholders, any liability of stockholders with respect to a
liquidating distribution is limited to the lesser of such stockholder’s pro rata share of the claim or the amount distributed to
the stockholder, and any liability of the stockholder would be barred after the third anniversary of the dissolution.
However, because we will not be complying with
Section 280 of the DGCL, Section 281(b) of the DGCL requires us to adopt a plan, based on facts known to us at such time that will provide
for our payment of all existing and pending claims or claims that may be potentially brought against us within the subsequent ten years.
However, because we are a blank check company, rather than an operating company, and our operations will be limited to searching for prospective
target businesses to acquire, the only likely claims to arise would be from our vendors (such as lawyers, investment bankers, etc.) or
prospective target businesses.
Approval of the Charter Amendment proposal will
constitute consent for Concord to instruct the trustee to (i) remove from the trust account an amount (the “Withdrawal Amount”)
equal to the pro rata portion of funds available in the trust account relating to the redeemed public shares and (ii) deliver to
the holders of such redeemed public shares their pro rata portion of the Withdrawal Amount. The remainder of such funds shall remain
in the trust account and be available for use by Concord to complete a business combination on or before the Extended Date. Holders of
public shares who do not redeem their public shares now, will retain their redemption rights and their ability to vote on a business combination
through the Extended Date if the Charter Amendment is approved.
The record date for the special meeting is [●],
2022. Record holders of Concord common stock at the close of business on the record date are entitled to vote or have their votes cast
at the special meeting. On the record date, there were [●] outstanding shares of Concord’s common stock. Concord’s warrants
do not have voting rights.
This proxy statement contains important information
about the special meeting and the proposals. Please read it carefully and vote your shares.
This proxy statement is dated [●], 2022 and
is first being mailed to stockholders on or about that date.
TABLE
OF CONTENTS
QUESTIONS AND ANSWERS
ABOUT THE SPECIAL MEETING
These Questions and Answers are only summaries
of the matters they discuss. They do not contain all of the information that may be important to you. You should read carefully the entire
document, including the annex to this proxy statement.
Q. Why am I receiving this proxy statement? |
A. This proxy statement and the accompanying materials are being sent
to you in connection with the solicitation of proxies by the Board, for use at the special meeting of stockholders to be held on [●],
2022 at 11:00 a.m., local time, at the offices of Greenberg Traurig, LLP, located at 1750 Tysons Boulevard, Suite 1000, McLean, Virginia
22102, or at any adjournments or postponements thereof. This proxy statement summarizes the information that you need to make an informed
decision on the proposals to be considered at the special meeting.
Concord is a blank check company formed for the purpose of effecting
a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses.
In December 2020, Concord consummated its IPO from which it derived gross proceeds of $276 million, including proceeds from the exercise
of the underwriters’ over-allotment option. Like most blank check companies, our charter provides for the return of the IPO proceeds
held in trust to the holders of shares of common stock sold in the IPO if no qualifying business combinations are consummated on or before
a certain date (in our case, December 10, 2022). The Board believes that it is in the best interests of the stockholders to continue Concord’s
existence until the Extended Date in order to allow Concord more time to complete such business combination and is submitting this proposal
to the stockholders to vote upon. In addition, we are proposing a measure to direct the chairman of the special meeting to adjourn the
special meeting to a later date or dates, if necessary, to permit further solicitation and vote of proxies if, based upon the tabulated
vote at the time of the special meeting, there are not sufficient votes to approve the foregoing proposal. |
Q. What is being voted on? |
A. You are being asked to vote on:
· a
proposal to amend Concord’s charter to extend the date by which Concord has to consummate a business combination to the Extended
Date; and
· a
proposal to direct the chairman of the special meeting to adjourn the special meeting to a later date or dates, if necessary, to permit
further solicitation and vote of proxies if, based upon the tabulated vote at the time of the special meeting, there are not sufficient
votes to approve the foregoing proposal.
The Charter Amendment proposal is essential to the implementation of
the Board’s plan to extend the date that Concord has to complete a business combination. Approval of the Charter Amendment is a
condition to the implementation of the Extension.
If the Extension is implemented, the stockholders’ approval of
the Charter Amendment proposal will constitute consent for Concord to remove the Withdrawal Amount from the trust account, deliver to
the holders of such redeemed public shares their pro rata portion of the Withdrawal Amount and retain the remainder of the funds
in the trust account for Concord’s use in connection with consummating a business combination on or before the Extended Date. |
|
If the Charter Amendment proposal is approved and the Extension is
implemented, the removal of the Withdrawal Amount from the trust account in connection with the Election will reduce the amount held in
the trust account following the Election. Concord cannot predict the amount that will remain in the trust account if the Charter Amendment
proposal is approved; and the amount remaining in the trust account may be significantly reduced from the approximately $279,177,550 million
that was in the trust account as of June 30, 2022. In such event, Concord may need to obtain additional funds to complete a business combination
and there can be no assurance that such funds will be available on terms acceptable to the parties or at all.
If the Charter Amendment proposal is not approved and we have not consummated
a business combination by December 10, 2022, or if the Charter Amendment proposal is approved and we have not consummated a business combination
by the Extended Date, we will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible
but no more than ten business days thereafter subject to lawfully available funds therefor, redeem 100% of the public shares, at a per-share
price, payable in cash, equal to the aggregate amount then on deposit in the trust account, including interest (which interest shall be
net of taxes payable, and less up to $100,000 of interest to pay dissolution expenses), divided by the number of then outstanding public
shares, which redemption will completely extinguish rights of the public stockholders, as stockholders (including the right to receive
further liquidating distributions, if any), subject to applicable law, and (iii) as promptly as reasonably possible following such redemption,
subject to the approval of the remaining stockholders and the Board in accordance with applicable law, liquidate and dissolve, subject
in each case to our obligations under Delaware law to provide for claims of creditors and the requirements of other applicable law. Concord’s
initial stockholders have waived their rights to participate in any liquidation distribution with respect to their founder shares. There
will be no distribution from the trust account with respect to our warrants, which will expire worthless in the event we wind up. Concord
will pay the costs of liquidation from its remaining assets held outside of the trust account. |
Q.
Will I have an opportunity to vote for directors at the meeting? |
A. Under our charter, holders of our Class B common stock have
the exclusive right to elect, remove and replace any director. Our initial stockholders are consequently the only stockholders entitled
to elect directors. Our initial stockholders advised that they intend to elect directors to our board of directors pursuant to an
action by written consent on or about the date of the special meeting. |
Q. Why is the Company proposing the Charter Amendment proposal? |
A. Concord’s charter provides for the return of the IPO proceeds
held in trust to the holders of shares of common stock sold in the IPO if no qualifying business combination is consummated on or before
December 10, 2022. Accordingly, the trust agreement provides for the trustee to liquidate the trust account and distribute to each public
stockholder its pro rata share of such funds if a qualifying business combination is not consummated on or before such date provided
in Concord’s charter. As we explain below, we do not believe Concord will be able to complete the Transaction by that date. We are
asking for an extension of this timeframe in order to complete an initial business combination.
While we have entered into the Transaction Agreement, the Board currently
believes that there will not be sufficient time before December 10, 2022 to hold a special meeting to vote for stockholder approval of
the Transaction and consummate the Transaction. Accordingly, our Board believes that in order to be able to consummate the Transaction,
we will need to obtain the Extension.
Because Concord will not be able to consummate a business combination
within the permitted time period, we have determined to seek stockholder approval to extend the date by which Concord has to complete
a business combination.
We believe that given our expenditure of time, effort and money on
the Transaction, circumstances warrant providing public stockholders an opportunity to consider the Transaction. Accordingly, the Board
is proposing the Charter Amendment to extend Concord’s corporate existence.
You are not being asked to vote on a business combination at this
time. If the Extension is implemented and you do not elect to redeem your public shares, you will retain the right to vote on any proposed
business combination when it is submitted to stockholders and the right to redeem your public shares for a pro rata portion of
the trust account in the event such business combination is approved and completed or the Company has not consummated a business combination
by the Extended Date. |
Q. Why should I vote for the Charter Amendment? |
A. The Board believes stockholders should have an opportunity to evaluate
the Transaction. Accordingly, the Board is proposing the Charter Amendment to extend the date by which Concord has to complete a business
combination until the Extended Date and to allow for the Election. The Extension would give the Company the opportunity to hold a stockholder
vote for the approval of the Transaction; without the Extension, the Board does not believe that the Transaction will be able to be consummated. |
|
The affirmative vote of the holders of at least 65% of all the outstanding shares of common stock is required to effect an amendment to Concord’s Charter, including any amendment that would extend its corporate existence beyond December 10, 2022. Additionally, Concord’s charter requires that all public stockholders have an opportunity to redeem their public shares in the case Concord’s corporate existence is extended. We believe that this charter provision was included to protect Concord stockholders from having to sustain their investments for an unreasonably long period if Concord failed to find a suitable business combination in the timeframe contemplated by the charter. Given Concord’s expenditure of time, effort and money on the proposed Transaction, circumstances warrant providing public stockholders an opportunity to consider the proposed Transaction, inasmuch as Concord is also affording stockholders who wish to redeem their public shares the opportunity to do so, as required under its charter. Accordingly, we believe the Extension is consistent with Concord’s charter and IPO prospectus. |
Q. How do the Concord insiders intend to vote their shares? |
A. All of Concord’s directors, executive officers and their respective
affiliates are expected to vote any common stock over which they have voting control (including any public shares owned by them) in favor
of the Charter Amendment proposal and, if presented, the Adjournment proposal.
Concord’s directors, executive officers and their respective
affiliates are not entitled to redeem their founder shares. With respect to shares purchased in the open market by Concord’s directors,
executive officers and their respective affiliates, such public shares may be redeemed. On the record date, Concord’s directors,
executive officers and their affiliates beneficially owned and were entitled to vote [●] founder shares, representing approximately
[●]% of Concord’s issued and outstanding common stock. Concord’s directors, executive officers and their affiliates
did not beneficially own any public shares as of such date. |
Q. What vote is required to approve each of the proposals? |
A. Approval of the Charter Amendment will require the affirmative vote of holders of at least 65% of Concord’s outstanding common stock on the record date. Approval of the proposal to direct the chairman of the special meeting to adjourn the special meeting requires the affirmative vote of a majority of the votes cast by the stockholders present in person or by proxy at the special meeting. Abstentions will be counted in connection with the determination of whether a valid quorum is established, but will have no effect on the approval of the Adjournment Proposal. With respect to the Charter Amendment proposal, abstentions and broker non-votes will have the same effect as “AGAINST” votes. |
Q. What if I don’t want to vote for the Charter Amendment proposal? |
A. If you do not want the Charter Amendment to be approved, you must abstain, not vote, or vote against the proposal. If the Charter Amendment is approved, and the Extension is implemented, the Withdrawal Amount will be withdrawn from the trust account and paid to the redeeming public stockholders. |
Q. Will you seek any further extensions to liquidate the trust account? |
A. Other than the extension until the Extended Date as described in this proxy statement, Concord does not currently anticipate seeking any further extension to consummate a business combination. Concord has provided that all holders of public shares, including those who vote for the Charter Amendment, may elect to redeem their public shares into their pro rata portion of the trust account and should receive the funds shortly after the special meeting which is scheduled for [●], 2022. Those holders of public shares who elect not to redeem their shares now shall retain redemption rights with respect to future business combinations, or, if Concord does not consummate a business combination by the Extended Date, such holders shall be entitled to their pro rata portion of the trust account on such date. |
Q. What happens if the Charter Amendment is not approved? |
A. If the Charter Amendment is not approved and we have not consummated a business combination by December 10, 2022, we will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but no more than ten business days thereafter subject to lawfully available funds therefor, redeem 100% of the public shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the trust account, including interest (which interest shall be net of taxes payable, and less up to $100,000 of interest to pay dissolution expenses), divided by the number of then outstanding public shares, which redemption will completely extinguish rights of the public stockholders, as stockholders (including the right to receive further liquidating distributions, if any), subject to applicable law, and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the remaining stockholders and the Board in accordance with applicable law, liquidate and dissolve, subject in each case to our obligations under Delaware law to provide for claims of creditors and the requirements of other applicable law. Concord’s initial stockholders waived their rights to participate in any liquidation distribution with respect to their founder shares. There will be no distribution from the trust account with respect to our warrants which will expire worthless in the event we wind up. We will pay the costs of liquidation from our remaining assets held outside of the trust account, which we believe are sufficient for such purposes. |
Q. If the Charter Amendment proposal is approved, what happens next? |
A. Concord will continue its efforts to obtain approval for the Transaction
at a special meeting of its stockholders and consummate the closing of the Transaction prior to the Extended Date.
Concord is seeking approval of the Charter Amendment because Concord
will not be able to obtain approval for the Transaction at a special meeting of its stockholders and consummate the closing of the Transaction
prior to December 10, 2022.
Upon approval by holders of at least 65% of the common stock outstanding
as of the record date of the Charter Amendment proposal, Concord will file an amendment to the charter with the Secretary of State of
the State of Delaware in the form of Annex A hereto. Concord will remain a reporting company under the Securities Exchange Act
of 1934, as amended (the “Exchange Act”) and its units, Class A common stock and warrants will remain publicly traded.
If the Charter Amendment proposal is approved, the removal of the Withdrawal
Amount from the trust account will reduce the amount remaining in the trust account and increase the percentage interest of Concord’s
common stock held by Concord’s directors and officers through the founder shares. Notwithstanding stockholder approval of the Charter
Amendment proposal, our Board will retain the right to abandon and not implement the Charter Amendment at any time without any further
action by our stockholders. |
|
If the Charter Amendment proposal is approved, but Concord does not
consummate a business combination by the Extended Date, we will (i) cease all operations except for the purpose of winding up, (ii) as
promptly as reasonably possible but no more than ten business days thereafter subject to lawfully available funds therefor, redeem 100%
of the public shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the trust account, including
interest (which interest shall be net of taxes payable, and less up to $100,000 of interest to pay dissolution expenses), divided by the
number of then outstanding public shares, which redemption will completely extinguish rights of the public stockholders, as stockholders
(including the right to receive further liquidating distributions, if any), subject to applicable law, and (iii) as promptly as reasonably
possible following such redemption, subject to the approval of the remaining stockholders and the Board in accordance with applicable
law, liquidate and dissolve, subject in each case to our obligations under Delaware law to provide for claims of creditors and the requirements
of other applicable law.
Concord’s initial stockholders waived their rights to participate
in any liquidation distribution with respect to their founder shares. There will be no distribution from the trust account with respect
to our warrants which will expire worthless in the event we wind up. We will pay the costs of liquidation from our remaining assets held
outside of the trust account, which we believe are sufficient for such purposes. |
Q. Would I still be able to exercise my redemption rights if I vote against the proposed business combination? |
A. Unless you elect to redeem all of your shares at this special meeting,
you will be able to vote on any proposed business combination when it is submitted to stockholders. If you disagree with the business
combination, you will retain your right to redeem your public shares upon consummation of a business combination in connection with the
stockholder vote to approve the business combination, subject to any limitations set forth in Concord’s charter. |
Q. How do I change my vote? |
A. If you have submitted a proxy to vote your shares and wish to change your vote, you may do so by delivering a later-dated, signed proxy card to Morrow Sodali LLC, Concord’s proxy solicitor, prior to the date of the special meeting or by voting in person at the special meeting. Attendance at the special meeting alone will not change your vote. You also may revoke your proxy by sending a notice of revocation to: Morrow Sodali LLC, 333 Ludlow Street, 5th Floor, South Tower, Stamford CT 06902. |
Q. How are votes counted? |
A. Votes will be counted by the inspector of election appointed for the meeting, who will separately count “FOR” and “AGAINST” votes, abstentions and broker non-votes. The Charter Amendment proposal must be approved by the affirmative vote of at least 65% of the outstanding shares as of the record date of Concord’s common stock. The Adjournment Proposal must be approved by the affirmative vote of a majority of the votes cast by the stockholders present in person or by proxy at the special meeting. |
|
With respect to the Charter Amendment proposal, abstentions and broker non-votes will have the same effect as “AGAINST” votes. The approval of the Adjournment Proposal requires the affirmative vote of a majority of the votes cast by the stockholders present in person or by proxy at the special meeting. Accordingly, a stockholder’s failure to vote by proxy or to vote in person at the Special Meeting will not be counted towards the number of shares of common stock required to validly establish a quorum, and if a valid quorum is otherwise established, it will have no effect on the outcome of any vote on the Adjournment Proposal. If your shares are held by your broker as your nominee (that is, in “street name”), you may need to obtain a proxy form from the institution that holds your shares and follow the instructions included on that form regarding how to instruct your broker to vote your shares. If you do not give instructions to your broker, your broker can vote your shares with respect to “discretionary” items, but not with respect to “non-discretionary” items. Discretionary items are proposals considered routine under the rules of the New York Stock Exchange applicable to member brokerage firms. These rules provide that for routine matters your broker has the discretion to vote shares held in street name in the absence of your voting instructions. On non-discretionary items for which you do not give your broker instructions, the shares will be treated as broker non-votes. |
Q. If my shares are held in “street name,” will my broker automatically vote them for me? |
A. With respect to the Charter Amendment proposal and the Adjournment Proposal, your broker can vote your shares only if you provide them with instructions on how to vote. You should instruct your broker to vote your shares. Your broker can tell you how to provide these instructions. |
Q. What is a quorum requirement? |
A. A quorum of stockholders is necessary to hold a valid meeting. A
quorum will be present with regard to each of the Charter Amendment and the Adjournment Proposal if at least a majority of the outstanding
shares of common stock on the record date are represented by stockholders present at the meeting or by proxy.
Your shares will be counted towards the quorum only if you submit a
valid proxy (or one is submitted on your behalf by your broker, bank or other nominee) or if you vote in person at the special meeting.
Abstentions and broker non-votes will be counted towards the quorum requirement. If there is no quorum, the chairman of the special meeting
may adjourn the special meeting to another date. |
Q. Who can vote at the special meeting? |
A. Holders of our Class A common stock and Class B common stock as
of the close of business on [●], 2022, the record date for the meeting, may vote at the special meeting. As of the record date,
there were [●] shares of our Class A common stock outstanding and [●] shares of our Class B common stock outstanding. Our
Class A common stock and Class B common stock will vote as a single class on all matters described in this proxy statement for which your
vote is being solicited. Each share of Class A common stock and Class B common stock is entitled to one vote on each matter properly brought
before the special meeting. Our Class A common stock and Class B common stock are collectively referred to in this proxy statement as
our common stock.
Stockholder of Record: Shares Registered in Your Name. If on
the record date your shares were registered directly in your name with Concord’s transfer agent, Continental Stock Transfer &
Trust Company, then you are a stockholder of record. As a stockholder of record, you may vote in person at the special meeting or vote
by proxy. Whether or not you plan to attend the special meeting in person, we urge you to fill out and return the enclosed proxy card
to ensure your vote is counted.
Beneficial Owner: Shares Registered in the Name of a Broker or Bank.
If on the record date your shares were held, not in your name, but rather in an account at a brokerage firm, bank, dealer, or other similar
organization, then you are the beneficial owner of shares held in “street name” and these proxy materials are being forwarded
to you by that organization. As a beneficial owner, you have the right to direct your broker or other agent on how to vote the shares
in your account. You are also invited to attend the special meeting. However, since you are not the stockholder of record, you may not
vote your shares in person at the special meeting unless you request and obtain a valid proxy from your broker or other agent. |
Q. How does the Board recommend I vote? |
A. After careful consideration of the terms and conditions of these
proposals, the Board has determined that the Charter Amendment is fair to and in the best interests of Concord and its stockholders. The
Board recommends that Concord’s stockholders vote “FOR” the Charter Amendment. In addition, if presented, the Board
recommends that you vote “FOR” the Adjournment Proposal. |
Q. What interests do the Company’s directors and officers have in the approval of the proposals? |
A. Concord’s directors and officers have interests in the proposals that may be different from, or in addition to, your interests as a stockholder. These interests include ownership of founder shares and warrants that may become exercisable in the future, committed loans by them, that if drawn upon, will not be repaid in the event of our winding up and the possibility of future compensatory arrangements. See the section entitled “The Charter Amendment Proposal—Interests of Concord’s Directors and Officers.” |
Q. What if I object to the Charter Amendment? Do I have appraisal rights? |
A. If you do not want the Charter Amendment to be approved, you must vote against the proposal, abstain from voting or refrain from voting. If holders of public shares do not elect to redeem their public shares, such holders shall retain redemption rights in connection with any future business combination Concord proposes. You will still be entitled to make the Election if you vote against, abstain or do not vote on the Charter Amendment. In addition, public stockholders who do not make the Election would be entitled to redemption if the Company has not completed a business combination by the Extended Date. Concord stockholders do not have appraisal rights in connection with the Charter Amendment under the DGCL. |
Q. What happens to the Concord warrants if the Charter Amendment is not approved? |
A. If the Charter Amendment is not approved and we have not consummated a business combination by December 10, 2022, we will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but no more than ten business days thereafter subject to lawfully available funds therefor, redeem 100% of the public shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the trust account, including interest (which interest shall be net of taxes payable, and less up to $100,000 of interest to pay dissolution expenses), divided by the number of then outstanding public shares, which redemption will completely extinguish rights of the public stockholders, as stockholders (including the right to receive further liquidating distributions, if any), subject to applicable law, and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the remaining stockholders and the Board in accordance with applicable law, liquidate and dissolve, subject in each case to our obligations under Delaware law to provide for claims of creditors and the requirements of other applicable law. |
Q. What happens to the Concord warrants if the Charter Amendment is approved? |
A. If the Charter Amendment proposal is approved, Concord will continue to attempt to complete the Transaction by the Extended Date, and will retain the blank check company restrictions previously applicable to it. The warrants will remain outstanding in accordance with their terms and will become exercisable 30 days after the completion of a business combination. The warrants will expire at 5:00 p.m., New York City time, five years after the completion of the initial business combination or earlier upon redemption or liquidation. |
Q. What do I need to do now? |
A. Concord urges you to read carefully and consider the information contained in this proxy statement, including the annex, and to consider how the proposals will affect you as a Concord stockholder. You should then vote as soon as possible in accordance with the instructions provided in this proxy statement and on the enclosed proxy card. |
Q. How do I vote? |
A. If you are a holder of record of Concord common stock, you may vote
in person at the special meeting or by submitting a proxy for the special meeting. Whether or not you plan to attend the special meeting
in person, we urge you to vote by proxy to ensure your vote is counted. You may submit your proxy by completing, signing, dating and returning
the enclosed proxy card in the accompanying pre-addressed postage paid envelope. You may still attend the special meeting and vote in
person if you have already voted by proxy.
If your shares of Concord common stock are held in “street name”
by a broker or other agent, you have the right to direct your broker or other agent on how to vote the shares in your account. You are
also invited to attend the special meeting. However, if you are not the stockholder of record, you may not vote your shares in person
at the special meeting unless you request and obtain a valid proxy from your broker or other agent. |
Q. How do I redeem my shares of Concord common stock? |
A. If the Extension is implemented, each public stockholder may seek
to redeem such stockholder’s public shares for its pro rata portion of the funds available in the trust account, less any
taxes owed on such funds but not yet paid. You will also be able to redeem your public shares in connection with any stockholder vote
to approve a proposed business combination, or if the Company has not consummated a business combination by the Extended Date.
In connection with tendering your shares for redemption, you must elect
either to physically tender your share certificates to Continental Stock Transfer & Trust Company, the Company’s transfer agent,
at Continental Stock Transfer & Trust Company, One State Street, 30th Floor, New York, New York 10004-1561, Attn: Mark Zimkind, mzimkind@continentalstock.com],
at least two business days prior to the special meeting or to deliver your shares to the transfer agent electronically using The Depository
Trust Company’s DWAC (Deposit/Withdrawal At Custodian) System, which election would likely be determined based on the manner in
which you hold your shares.
Certificates that have not been tendered in accordance with these procedures
at least two business days prior to the special meeting will not be redeemed for cash. In the event that a public stockholder tenders
its shares and decides prior to the special meeting that it does not want to redeem its shares, the shareholder may withdraw the tender.
If you delivered your shares for redemption to our transfer agent and decide prior to the special meeting not to redeem your shares, you
may request that our transfer agent return the shares (physically or electronically). You may make such request by contacting our transfer
agent at the address listed above. |
Q. What should I do if I receive more than one set of voting materials? |
A. You may receive more than one set of voting materials, including multiple copies of this proxy statement and multiple proxy cards or voting instruction cards, if your shares are registered in more than one name or are registered in different accounts. For example, if you hold your shares in more than one brokerage account, you will receive a separate voting instruction card for each brokerage account in which you hold shares. Please complete, sign, date and return each proxy card and voting instruction card that you receive in order to cast a vote with respect to all of your Concord shares. |
Q. Who is paying for this proxy solicitation? |
A. Concord will pay for the entire cost of soliciting proxies. Concord
has engaged Morrow Sodali LLC to assist in the solicitation of proxies for the special meeting. Morrow Sodali LLC will receive a
fee of $30,000, as well as reimbursement for certain costs and out-of-pocket expenses incurred by them in connection with their services,
all of which will be paid by Concord. In addition, officers and directors of Concord may solicit proxies by mail, telephone and personal
interview, for which no additional compensation will be paid, though they may be reimbursed for their out-of-pocket expenses. These
parties will not be paid any additional compensation for soliciting proxies. We may also reimburse brokerage firms, banks and other
agents for the cost of forwarding proxy materials to beneficial owners. |
Q. Who can help answer my questions? |
A. If you have questions, you may write or call Concord’s proxy
solicitor:
Morrow Sodali LLC
333 Ludlow Street, 5th Floor, South Tower
Stamford CT 06902
Tel: Toll-Free (800) 662-5200 or (203) 658-9400
Email: CND.info@investor.morrowsodali.com |
You may also obtain additional information about Concord from documents
filed with the SEC by following the instructions in the section entitled “Where You Can Find More Information.”
FORWARD-LOOKING
STATEMENTS
This proxy statement and the documents to which
we refer you in this proxy statement contain “forward-looking statements” as that term is defined by the Private Securities
Litigation Reform Act of 1995, which we refer to as the Act, and the federal securities laws. Any statements that do not relate to historical
or current facts or matters are forward-looking statements. You can identify some of the forward-looking statements by the use of forward-looking
words such as “anticipate,” “believe,” “plan,” “estimate,” “expect,” “intend,”
“should,” “may” and other similar expressions, although not all forward-looking statements contain these identifying
words. There can be no assurance that actual results will not materially differ from expectations. Such statements include, but are not
limited to, any statements relating to our ability to consummate a business combination, and any other statements that are not statements
of current or historical facts. These forward-looking statements are based on information available to Concord as of the date of the proxy
materials and current expectations, forecasts and assumptions and involve a number of risks and uncertainties. Accordingly, forward-looking
statements should not be relied upon as representing Concord’s views as of any subsequent date and Concord undertakes no obligation
to update forward-looking statements to reflect events or circumstances after the date they were made.
These forward-looking statements involve a number
of known and unknown risks and uncertainties or other assumptions that may cause actual results or performance to be materially different
from those expressed or implied by these forward-looking statements. Some factors that could cause actual results to differ include:
| ● | the ability of Concord to effect the Charter Amendment or consummate
a business combination, including the Transaction; |
| ● | unanticipated delays in the distribution of the funds from
the trust account; |
| ● | claims by third parties against the trust account; or |
| ● | the ability of Concord to finance and consummate a business
combination. |
You should carefully consider these risks, in
addition to the risk factors set forth herein and in our other filings with the SEC, including our Annual Report on Form 10-K for the
fiscal year ended December 31, 2021 (the “2021 annual report”) as well as in Amendment No. 6 to the Registration Statement
on Form S-4 filed by Circle on October 20, 2022. The documents we file with the SEC, including those referred to above, also discuss
some of the risks that could cause actual results to differ from those contained or implied in the forward-looking statements. See “Where
You Can Find More Information” for additional information about our filings.
RISK FACTORS
You should consider carefully all of the
risks described in our 2021 annual report, any subsequent Quarterly Report on Form 10-Q filed with the SEC and in the other
reports we file with the SEC before making a decision to invest in our securities. Furthermore, if any of the following events occur,
our business, financial condition and operating results may be materially adversely affected or we could face liquidation. In that event,
the trading price of our securities could decline, and you could lose all or part of your investment. The risks and uncertainties described
in the aforementioned filings and below are not the only ones we face. Additional risks and uncertainties that we are unaware of, or
that we currently believe are not material, may also become important factors that adversely affect our business, financial condition
and operating results or result in our liquidation.
If we are deemed to be an investment
company for purposes of the Investment Company Act of 1940, as amended (the “Investment Company Act”), we
would be required to institute burdensome compliance requirements and our activities would be severely restricted and, as a result, we
may abandon our efforts to consummate an initial business combination and liquidate.
On March 30, 2022, the SEC issued proposed
rules relating to certain activities of SPACs (the “SPAC Rule Proposals”), relating to, among other things, circumstances
in which SPACs could potentially be subject to the Investment Company Act and the regulations thereunder. The SPAC Rule Proposals would
provide a safe harbor for such companies from the definition of “investment company” under Section 3(a)(1)(A) of
the Investment Company Act, provided that a SPAC satisfies certain criteria, including a limited time period to announce and complete
a de-SPAC transaction. Specifically, to comply with the safe harbor, the SPAC Rule Proposals would require a company to file a Current
Report on Form 8-K announcing that it has entered into an agreement with a target company for an initial business combination
no later than 18 months after the effective date of its registration statement for its IPO (the “IPO Registration Statement”).
The company would then be required to complete its initial business combination no later than 24 months after the effective date
of the IPO Registration Statement.
Because the SPAC Rule Proposals have not yet
been adopted, there is currently uncertainty concerning the applicability of the Investment Company Act to a SPAC, including a company
that has not entered into a definitive agreement within 18 months after the effective date of the IPO Registration Statement or
that may not complete its initial business combination within 24 months after such date. While we have entered into a definitive
initial business combination agreement within 18 months after the effective date of our IPO Registration Statement, we do not expect
to complete our initial business combination within 24 months of such date. As a result, it is possible that a claim could be made
that we have been operating as an unregistered investment company.
If we are deemed to be an investment company
under the Investment Company Act, our activities would be severely restricted. In addition, we would be subject to burdensome compliance
requirements. We do not believe that our principal activities will subject us to regulation as an investment company under the Investment
Company Act. However, if we are deemed to be an investment company and subject to compliance with and regulation under the Investment
Company Act, we would be subject to additional regulatory burdens and expenses for which we have not allotted funds. As a result, unless
we are able to modify our activities so that we would not be deemed an investment company, we would expect to abandon our efforts to
complete an initial business combination and instead to liquidate.
To mitigate the risk that we might be
deemed to be an investment company for purposes of the Investment Company Act, we may, at any time, instruct the trustee to liquidate
the securities held in the trust account and instead to hold the funds in the trust account in cash until the earlier of the consummation
of an initial business combination or our liquidation. As a result, following the liquidation of securities in the trust account, we
would likely receive minimal interest, if any, on the funds held in the trust account, which would reduce the dollar amount the public
stockholders would receive upon any redemption or liquidation of the Company.
The funds in the trust account have, since
the IPO, been held only in U.S. government treasury obligations with a maturity of 185 days or less or in money market funds
investing solely in U.S. government treasury obligations and meeting certain conditions under Rule 2a-7 under the Investment
Company Act. However, to mitigate the risk of us being deemed to be an unregistered investment company (including under the subjective
test of Section 3(a)(1)(A) of the Investment Company Act) and thus subject to regulation under the Investment Company Act,
we may, at any time, on or prior to the 24-month anniversary of the effective date of the IPO Registration Statement, instruct the
trustee with respect to the trust account to liquidate the U.S. government treasury obligations or money market funds held in the
trust account and thereafter to hold all funds in the trust account in cash until the earlier of consummation of an initial business
combination or liquidation of the Company. Following such liquidation of the securities held in the trust account, we would likely receive
minimal interest, if any, on the funds held in the trust account. However, interest previously earned on the funds held in the trust
account still may be released to us to pay our taxes, if any, and certain other expenses as permitted. As a result, any decision to liquidate
the securities held in the trust account and thereafter to hold all funds in the trust account in cash would reduce the dollar amount
the public stockholders would receive upon any redemption or liquidation of the Company.
In addition, even prior to the 24-month anniversary
of the effective date of the IPO Registration Statement, we may be deemed to be an investment company. The longer that the funds in the
trust account are held in short-term U.S. government treasury obligations or in money market funds invested exclusively in such securities,
even prior to the 24-month anniversary, the greater the risk that we may be considered an unregistered investment company, in which
case we may be required to liquidate the Company. Accordingly, we may determine, in our discretion, to liquidate the securities held
in the trust account at any time, even prior to the 24-month anniversary, and instead hold all funds in the trust account in cash,
which would further reduce the dollar amount the public stockholders would receive upon any redemption or liquidation of the Company.
The Business Combination may be subject to U.S. foreign investment
regulations, which may impose conditions on the consummation of the Business Combination. In addition, future investments in the ordinary
shares of $0.001 each (nominal value) in the capital of Circle Internet Finance Public Limited Company (the “Topco”) may
be subject to U.S. foreign investment regulations.
Investments that involve the acquisition of,
or investment in, a U.S. business by a non-U.S. investor may be subject to U.S. laws that regulate foreign investments in U.S. businesses
and access by foreign persons to technology developed and produced in the United States. These laws include Section 721 of the Defense
Production Act of 1950, as amended by the Foreign Investment Risk Review Modernization Act of 2018, and the regulations at 31 C.F.R.
Parts 800 and 802, as amended, administered by the Committee on Foreign Investment in the United States (“CFIUS”).
Whether CFIUS has jurisdiction to review an
acquisition or investment transaction depends on, among other factors, the nature and structure of the transaction, including the level
of beneficial ownership interest and the nature of any information or governance rights involved. For example, investments that result
in “control” of a “U.S. business” by a “foreign person” (in each case, as such terms are defined
in 31 C.F.R. Part 800) are always subject to CFIUS jurisdiction. Significant CFIUS reform legislation, which was fully implemented through
regulations that became effective in 2020, expanded the scope of CFIUS’s jurisdiction to investments that do not result in control
of a U.S. business by a foreign person, but where they afford certain foreign investors certain information or governance rights in a
U.S. business that has a nexus to “critical technologies,” “covered investment critical infrastructure,” and/or
“sensitive personal data” (in each case, as such terms are defined in 31 C.F.R. Part 800).
The Business Combination will result in investments
by non-U.S. persons in various U.S. entities that could be considered by CFIUS to be a covered transaction that CFIUS would have authority
to review. For example, entities affiliated with Wide Palace Limited (IDG China), organized in Hong Kong with its principal place of business
outside of the United States, will indirectly hold between 10.7% and 11.0% of the issued and outstanding common stock of Circle, assuming
the No Redemption scenario and Maximum Redemption scenario, respectively, as defined in the Form S-4, Amendment No. 6 of Topco, filed
with the SEC on October 20, 2022. Other than Anita Sands, none of our directors or executive officers are foreign persons. While none
of the foregoing foreign persons or entities, nor any other foreign person or entity, are expected to “control” Circle or
any of its subsidiaries following the Business Combination, nor be afforded any of the information or governance rights set forth in 31
C.F.R. 800.211, CFIUS or another U.S. governmental agency could choose to review the Business Combination or past or proposed transactions
involving new or existing foreign investors in Circle, even if a filing with CFIUS is or was not required at the time of such transaction.
There can be no assurances that CFIUS or another
U.S. governmental agency will not choose to review the Business Combination. Any review and approval of an investment or transaction
by CFIUS may have outsized impacts on transaction certainty, timing, feasibility, and cost, among other things. CFIUS policies and agency
practices are rapidly evolving, and, in the event that CFIUS reviews the Business Combination or one or more proposed or existing investments
by investors, there can be no assurances that such investors will be able to maintain, or proceed with, such investments on terms acceptable
to the parties to the Business Combination or such investors. Among other things, CFIUS could seek to impose limitations or restrictions
on, or prohibit, investments by such investors (including, but not limited to, limits on purchasing our common stock, limits on information
sharing with such investors, requiring a voting trust, governance modifications, or forced divestiture, among other things), or CFIUS
could require us to divest a portion of Circle.
The process of government review, whether by
CFIUS or otherwise, could be lengthy. If CFIUS elects to review the Business Combination, the time necessary to complete such review
of the Business Combination or a decision by CFIUS to prohibit the Business Combination could prevent Concord from completing the Business
Combination with Circle prior to December 10, 2022 (or January 31, 2023 if the Charter Amendment proposal is approved by Concord’s
stockholders). If Concord is not able to consummate the Business Combination with Circle nor able to complete another business combination
by December 10, 2022 (or January 31, 2023 if the Charter Amendment proposal is approved by Concord’s stockholders), Concord will
(i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business
days thereafter, redeem 100% of the outstanding Public Shares, at a per share price, payable in cash, equal to the aggregate amount then
on deposit in the Trust Account, including interest not previously released to Concord to pay taxes (less taxes payable and up to $100,000
of such net interest to pay dissolution expenses), divided by the number of then outstanding Public Shares, which redemption will completely
extinguish Public Stockholders’ rights as stockholders (including the right to receive further liquidation distributions, if any),
subject to applicable law, and (iii) as promptly as reasonably possible following such redemption, subject to the approval of our remaining
stockholders and Concord’s board of directors, dissolve and liquidate, subject (in the case of (ii) and (iii) above) to our obligations
under Delaware law to provide for claims of creditors and the requirements of other applicable law. In addition, if Concord fails to
complete an initial business combination by December 10, 2022 (or January 31, 2023 if the Charter Amendment proposal is approved by Concord’s
stockholders), there will be no redemption rights or liquidating distributions with respect to the public warrants or the private placement
warrants, which will expire worthless.
BACKGROUND
Concord
We are a Delaware company incorporated in August
2020 for the purpose of effecting a merger, stock exchange, asset acquisition, stock purchase, reorganization or similar business combination
with one or more businesses.
In September 2020, our initial stockholders purchased
an aggregate of 7,187,500 founder shares for an aggregate purchase price of $25,000. On December 2, 2020, our sponsor forfeited 1,150,000
founder shares and CA Co-Investment LLC (an affiliate of one of the underwriters of the IPO) (“CA Co-Investment” and, together
with the sponsor, the “sponsors”) forfeited 287,500 founder shares, such that Concord’s initial stockholders owned an
aggregate of 5,750,000 founder shares. On December 7, 2020, Concord effected a stock dividend of 1,150,000 shares with respect to
Concord’s Class B common stock, resulting in Concord’s initial stockholders holding an aggregate of 6,900,000 founder
shares. The net proceeds of the IPO plus the proceeds of the sale of the private placement warrants were deposited in the trust account.
As of June 30, 2022, Concord had approximately $279,177,550 in the trust account.
On December
10, 2020, we consummated an IPO of 27,600,000 units, including the issuance of 3,600,000 units as a result of the exercise in full of
the underwriters’ over-allotment option, at $10.00 per unit, generating gross proceeds of $276,000,000. Simultaneously with the
closing of the offering, we consummated the private placement of 510,289 private units to the sponsor, and 241,711 private units to CA
Co-Investment, each at a price of $10.00 per private unit, generating total proceeds of $7,520,000. Following the closing of the IPO,
an aggregate of $10.00 per unit sold in the offering was held in the trust account.
The units began trading on December 7, 2020 on
the NYSE under the symbol “CND.U.” Commencing on January 28, 2021, the securities comprising the units began separate trading.
The units, Class A common stock and warrants are trading on the NYSE under the symbols “CND.U,” “CND,” and “CND
WS,” respectively.
On February 16, 2022, we entered into the Transaction
Agreement with Circle, Topco, and Merger Sub. Circle is a global financial technology firm that provides internet-native payments and
treasury infrastructure. Circle’s mission of raising global economic prosperity through the frictionless exchange of value is being
met through a series of transaction and treasury services that help businesses and financial institutions globally to take advantage of
the shift to a digital asset and blockchain powered global financial system. Circle is the principal operator of a U.S. dollar digital
stablecoin, USD Coin (USDC).
On June 7, 2022, Circle deposited $2,760,000 into
the trust account, representing $0.10 per public unit sold in the IPO, which enabled us to extend the period of time we have to consummate
our initial business combination by six months from June 10, 2022 to December 10, 2022.
The mailing address of Concord’s principal executive office is
Concord Acquisition Corp, 477 Madison Avenue, 22nd Floor, New York, New York 10022, and its telephone number is (212) 883-4330.
The Transaction
The proposed Transaction qualifies as an initial
business combination under Concord’s charter, but our Board does not believe that we will be able to complete the Transaction by
December 10, 2022. The Charter Amendment is essential to allowing Concord more time to seek to obtain approval for the Transaction at
a special meeting of its stockholders and to consummate the Transaction prior to the Extended Date. Approval of the Charter Amendment
is a condition to the implementation of the Extension. Concord believes that given its expenditure of time, effort and money on the proposed
Transaction, circumstances warrant providing public stockholders an opportunity to consider the proposed Transaction.
You are not being asked to vote on the Transaction
at this time. If the Extension is implemented and you do not elect to redeem your public shares, you will retain the right to vote on
any proposed business combination if and when it is submitted to stockholders and the right to redeem your public shares for a pro
rata portion of the trust account in the event such business combination is approved and completed or the Company has not consummated
a business combination by the Extended Date.
The Special Meeting
Date, Time and Place. The special meeting
of Concord’s stockholders will be held on [●], 2022 at 11:00 a.m., local time, at the offices of Greenberg Traurig, LLP, located
at 1750 Tysons Boulevard, Suite 1000, McLean, Virginia, 22102.
Voting Power; Record Date. You will be entitled
to vote or direct votes to be cast at the special meeting, if you owned shares of Concord’s common stock at the close of business
on [●], 2022, the record date for the special meeting. You will have one vote per proposal for each share you owned at that time.
Concord’s warrants do not carry voting rights.
Votes Required. The affirmative vote of
at least 65% of the outstanding shares of our common stock is required to approve the Charter Amendment. The Adjournment Proposal must
be approved by the affirmative vote of a majority of the votes cast by the stockholders present in person or by proxy at the special meeting.
If you do not vote (i.e., you “abstain” from voting on a proposal), your action will have the effect of a vote against the
Charter Amendment and no effect on the Adjournment Proposal. Likewise, abstentions and broker non-votes will have the effect of a vote
against the Charter Amendment and no effect on the Adjournment Proposal.
At the close of business on the record date, there
were [●] outstanding shares of common stock, including [●] public shares, each of which entitles its holder to cast one vote
per proposal.
If you do not want the Charter Amendment approved,
you should vote against the proposal or abstain from voting on the proposal. If you want to obtain your pro rata portion of the
trust account in the event the Extension is implemented, which will be paid shortly after the special meeting scheduled for [●],
2022, you must demand redemption of your shares. Holders of public shares may redeem their public shares regardless of whether they vote
for or against the Charter Amendment or abstain.
Proxies; Board Solicitation. Your proxy
is being solicited by the Board on the proposals being presented to stockholders at the special meeting to approve the Charter Amendment
and the Adjournment Proposal. No recommendation is being made as to whether you should elect to redeem your shares. Proxies may be solicited
in person or by telephone. If you grant a proxy, you may still revoke your proxy and vote your shares in person at the special meeting.
Concord has retained Morrow Sodali LLC to aid in
the solicitation of proxies. Morrow Sodali LLC will receive a fee of approximately $30,000, as well as reimbursement for certain costs
and out-of-pocket expenses incurred by them in connection with their services, all of which will be paid by Concord. In addition, officers
and directors of Concord may solicit proxies by mail, telephone, facsimile, and personal interview, for which no additional compensation
will be paid, though they may be reimbursed for their out-of-pocket expenses. Concord will bear the cost of preparing, assembling and
mailing the enclosed form of proxy, this proxy statement and other material which may be sent to stockholders in connection with this
solicitation. Concord may reimburse brokerage firms and other nominee holders for their reasonable expenses in sending proxies and proxy
material to the beneficial owners of our shares.
THE CHARTER AMENDMENT
PROPOSAL
Charter Amendment Proposal
Concord is proposing to amend its charter to extend
the date by which Concord has to consummate a business combination from December 10, 2022 to the Extended Date.
The Charter Amendment is essential to the implementation
of the Board’s plan to allow Concord more time to consummate a business combination. Approval of the Charter Amendment is a condition
to the implementation of the Extension.
If the Charter Amendment proposal is not approved
and we have not consummated a business combination by December 10, 2022, we will (i) cease all operations except for the purpose
of winding up, (ii) as promptly as reasonably possible but no more than ten business days thereafter subject to lawfully available funds
therefor, redeem 100% of the public shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the
trust account, including interest (which interest shall be net of taxes payable, and less up to $100,000 of interest to pay dissolution
expenses), divided by the number of then outstanding public shares, which redemption will completely extinguish rights of the public stockholders,
as stockholders (including the right to receive further liquidating distributions, if any), subject to applicable law, and (iii) as promptly
as reasonably possible following such redemption, subject to the approval of the remaining stockholders and the Board in accordance with
applicable law, liquidate and dissolve, subject in each case to our obligations under Delaware law to provide for claims of creditors
and the requirements of other applicable law. A copy of the proposed amendment to the charter of Concord is attached to this proxy statement
as Annex A.
Reasons for the Proposal
Concord’s IPO prospectus and charter provide
that Concord has until December 10, 2022 to consummate a business combination. The proposed Transaction qualifies as an initial business
combination under Concord’s charter, but the Company will not be able to complete the Transaction by December 10, 2022. The Charter
Amendment is essential to allowing Concord more time to obtain approval for the Transaction at a special meeting of its stockholders and
consummate the Transaction. Approval of the Charter Amendment is a condition to the implementation of the Extension. Concord believes
that given its expenditure of time, effort and money on the proposed Transaction, circumstances warrant providing public stockholders
an opportunity to consider the proposed Transaction. The affirmative vote of the holders of at least 65% of all outstanding shares of
common stock is required to extend Concord’s corporate existence. Additionally, Concord’s IPO prospectus and charter provide
for all public stockholders to have an opportunity to redeem their public shares in the case Concord’s corporate existence is extended
as described above. Because Concord continues to believe that a business combination would be in the best interests of Concord’s
stockholders, and because Concord will not be able to consummate a business combination within the permitted time period, Concord has
determined to seek stockholder approval to extend the date by which Concord has to complete a business combination beyond December 10,
2022 to the Extended Date.
We believe that the foregoing charter provisions
were included to protect Concord stockholders from having to sustain their investments for an unreasonably long period, if Concord failed
to find a suitable business combination in the timeframe contemplated by the charter. We also believe, however, that given Concord’s
time, effort and money on the proposed Transaction, circumstances warrant providing public stockholders an opportunity to consider the
proposed Transaction, inasmuch as Concord is also affording stockholders who wish to redeem their public shares the opportunity to do
so, as required under its charter. Accordingly, the Extension is consistent with Concord’s charter and IPO prospectus.
If the Charter Amendment Proposal Is Not Approved
If the Charter Amendment proposal is not approved
and we have not consummated a business combination by December 10, 2022, we will (i) cease all operations except for the purpose
of winding up, (ii) as promptly as reasonably possible but no more than ten business days thereafter subject to lawfully available funds
therefor, redeem 100% of the public shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the
trust account, including interest (which interest shall be net of taxes payable, and less up to $100,000 of interest to pay dissolution
expenses), divided by the number of then outstanding public shares, which redemption will completely extinguish rights of the public stockholders,
as stockholders (including the right to receive further liquidating distributions, if any), subject to applicable law, and (iii) as promptly
as reasonably possible following such redemption, subject to the approval of the remaining stockholders and the Board in accordance with
applicable law, liquidate and dissolve, subject in each case to our obligations under Delaware law to provide for claims of creditors
and the requirements of other applicable law. Concord’s initial stockholders have waived their rights to participate in any liquidation
distribution with respect to their founder shares. There will be no distribution from the trust account with respect to Concord’s
warrants which will expire worthless in the event we wind up. Concord will pay the costs of liquidation from its remaining assets held
outside of the trust account.
If the Charter Amendment proposal is not approved,
the Company will not effect the Extension, and in the event the Company does not complete a business combination on or before December
10, 2022, the trust account will be liquidated and distributed to the public stockholders on a pro rata basis as described above.
If the Charter Amendment Proposal Is Approved
If the Charter Amendment proposal is approved,
Concord will file an amendment to the charter with the Secretary of State of the State of Delaware in the form of Annex A hereto.
Concord will remain a reporting company under the Exchange Act and its units, Class A common stock and warrants will remain publicly traded.
Concord will then continue to work to complete a business combination by the Extended Date. Notwithstanding stockholder approval of the
Charter Amendment proposal, our Board will retain the right to abandon and not implement the Charter Amendment at any time without any
further action by our stockholders.
If the Charter Amendment proposal is approved,
but Concord does not consummate a business combination by the Extended Date, we will (i) cease all operations except for the purpose of
winding up, (ii) as promptly as reasonably possible but no more than ten business days thereafter subject to lawfully available funds
therefor, redeem 100% of the public shares, at a per-share price, payable in cash, equal to the aggregate amount then on deposit in the
trust account, including interest (which interest shall be net of taxes payable, and less up to $100,000 of interest to pay dissolution
expenses), divided by the number of then outstanding public shares, which redemption will completely extinguish rights of the public stockholders,
as stockholders (including the right to receive further liquidating distributions, if any), subject to applicable law, and (iii) as promptly
as reasonably possible following such redemption, subject to the approval of the remaining stockholders and the Board in accordance with
applicable law, liquidate and dissolve, subject in each case to our obligations under Delaware law to provide for claims of creditors
and the requirements of other applicable law.
Concord’s initial stockholders waived their
rights to participate in any liquidation distribution with respect to their founder shares. There will be no distribution from the trust
account with respect to our rights or warrants which will expire worthless in the event we wind up. Concord will pay the costs of liquidation
from its remaining assets held outside of the trust account, which it believes are sufficient for such purposes.
You are not being asked to vote on a business combination at this
time. If the Extension is implemented and you do not elect to redeem your public shares, you will retain the right to vote on any proposed
business combination when it is submitted to stockholders and the right to redeem your public shares for a pro rata portion of
the trust account in the event such business combination is approved and completed or the Company has not consummated a business combination
by the Extended Date.
If the Charter Amendment proposal is approved,
and the Extension is implemented, the removal of the Withdrawal Amount from the trust account in connection with the Election will reduce
the amount held in the trust account and Concord’s net asset value. Concord cannot predict the amount that will remain in the trust
account if the Charter Amendment proposal is approved; and the amount remaining in the trust account may be significantly reduced from
the approximately $279,177,550 that was in the trust account as of June 30, 2022.
Redemption Rights
If the Charter Amendment proposal is approved,
we will provide the public stockholders making the Election, the opportunity to receive, at the time the Charter Amendment becomes effective,
and in exchange for the surrender of their shares, a pro rata portion of the funds available in the trust account, less any taxes
owed on such funds but not yet paid. You will also be able to redeem your public shares in connection with any stockholder vote to approve
a proposed business combination, or if the Company has not consummated a business combination by the Extended Date.
TO DEMAND REDEMPTION, PRIOR TO 5:00 P.M. EASTERN
TIME ON [•], 2022 (TWO BUSINESS DAYS BEFORE THE SPECIAL MEETING), YOU SHOULD ELECT EITHER TO PHYSICALLY TENDER YOUR SHARE CERTIFICATES
TO OUR TRANSFER AGENT OR TO DELIVER YOUR SHARES TO OUR TRANSFER AGENT ELECTRONICALLY USING DTC’S DWAC (DEPOSIT/WITHDRAWAL AT CUSTODIAN),
AS DESCRIBED HEREIN. YOU SHOULD ENSURE THAT YOUR BANK OR BROKER COMPLIES WITH THE REQUIREMENTS IDENTIFIED ELSEWHERE HEREIN.
In connection with tendering your shares for redemption,
you must elect either to physically tender your stock certificates to Continental Stock Transfer & Trust Company, the Company’s
transfer agent, at Continental Stock Transfer & Trust Company, One State Street, 30th Floor, New York, New York 10004-1561, Attn:
Mark Zimkind, mzimkind@continentalstock.com, prior to the vote for the Charter Amendment or to deliver your shares to the transfer agent
electronically using The Depository Trust Company’s DWAC (Deposit/Withdrawal At Custodian) System, which election would likely be
determined based on the manner in which you hold your shares. The requirement for physical or electronic delivery prior to the vote at
the special meeting ensures that a redeeming holder’s election is irrevocable once the Charter Amendment are approved. In furtherance
of such irrevocable election, stockholders making the election will not be able to tender their shares after the vote at the special meeting.
Through the DWAC system, this electronic delivery
process can be accomplished by the stockholder, whether or not it is a record holder or its shares are held in “street name,”
by contacting the transfer agent or its broker and requesting delivery of its shares through the DWAC system. Delivering shares physically
may take significantly longer. In order to obtain a physical stock certificate, a stockholder’s broker and/or clearing broker, DTC,
and the Company’s transfer agent will need to act together to facilitate this request. There is a nominal cost associated with the
above-referenced tendering process and the act of certificating the shares or delivering them through the DWAC system. The transfer agent
will typically charge the tendering broker $45 and the broker would determine whether or not to pass this cost on to the redeeming holder.
It is the Company’s understanding that stockholders should generally allot at least two weeks to obtain physical certificates from
the transfer agent. The Company does not have any control over this process or over the brokers or DTC, and it may take longer than two
weeks to obtain a physical stock certificate. Such stockholders will have less time to make their investment decision than those stockholders
that deliver their shares through the DWAC system. Stockholders who request physical stock certificates and wish to redeem may be unable
to meet the deadline for tendering their shares before exercising their redemption rights and thus will be unable to redeem their shares.
Certificates that have not been tendered in accordance
with these procedures prior to the vote for the Charter Amendment will not be redeemed for a pro rata portion of the funds held
in the trust account. In the event that a public stockholder tenders its shares and decides prior to the vote at the special meeting that
it does not want to redeem its shares, the stockholder may withdraw the tender. If you delivered your shares for redemption to our transfer
agent and decide prior to the vote at the special meeting not to redeem your shares, you may request that our transfer agent return the
shares (physically or electronically). You may make such request by contacting our transfer agent at the address listed above. In the
event that a public stockholder tenders shares and the Charter Amendment is not approved or is abandoned, these shares will not be redeemed
and the physical certificates representing these shares will be returned to the stockholder promptly following the determination that
the Charter Amendment will not be approved or will be abandoned. The Company anticipates that a public stockholder who tenders shares
for redemption in connection with the vote to approve the Charter Amendment would receive payment of the redemption price for such shares
soon after the completion of the Charter Amendment. The transfer agent will hold the certificates of public stockholders that make the
election until such shares are redeemed for cash or returned to such stockholders.
If properly demanded, the Company will redeem each
public share for a pro rata portion of the funds available in the trust account, less any taxes owed on such funds but not yet
paid, calculated as of two days prior to the filing of the amendment to the charter. As of June 30, 2022, this would amount to approximately
$10.12 per share, based on $279,177,550 held in the trust account as of June 30, 2022 (which amount includes an increase of $0.10 per
public share as a result of the Extension Payment, but does not yet take into account the removal of interest earned on the funds held
in the trust account that may be used by us to pay our taxes payable). The closing price of Concord’s common stock on [●],
2022 was $[●], 2022. Accordingly, if the market price were to remain the same until the date of the special meeting, exercising
redemption rights would result in a public stockholder receiving $[●] more for each share than if such stockholder sold the shares
in the open market.
If you exercise your redemption rights, you will
be exchanging your shares of Class A common stock for cash and will no longer own the shares. You will be entitled to receive cash for
these shares only if you properly demand redemption and tender your stock certificate(s) to the Company’s transfer agent at least
two business days prior to the special meeting. If the Charter Amendment is not approved or if it is abandoned, these shares will be returned
promptly following the special meeting as described above.
Possible Claims Against and Impairment of the Trust Account
To protect amounts held in the trust account, our sponsor has agreed
that it will be liable to us if and to the extent any claims by a third party for services rendered or products sold to us, or a prospective
target business with which we have discussed entering into a transaction agreement, reduce the amount of funds in the trust account to
below: (1) $10.00 per public share; or (2) such lesser amount per public share held in the trust account as of the date of the liquidation
of the trust account due to reductions in the value of the trust assets, in each case net of the amount of interest which may be withdrawn
to pay taxes, except as to any claims by a third party who executed a waiver of any and all rights to seek access to the trust account
and except as to any claims under our indemnity of the underwriters of our IPO against certain liabilities, including liabilities under
the Securities Act. Moreover, in the event that an executed waiver is deemed to be unenforceable against a third party, our sponsor will
not be responsible to the extent of any liability for such third-party claims. We have not independently verified whether our sponsor,
has sufficient funds to satisfy its indemnity obligations and believe that our sponsor’s only assets are securities of Concord and,
therefore, our sponsor may not be able to satisfy those obligations. We have not asked our sponsor to reserve for such obligations. As
a result, if we liquidate, the per-share distribution from the trust account could be less than $10.00 due to claims or potential claims
of creditors. We will distribute to all of our public stockholders, in proportion to their respective equity interests, an aggregate amount
then on deposit in the trust account, including any interest earned on the funds held in the trust account net of interest that may be
used by us to pay our taxes payable.
In the event that the proceeds in the trust account
are reduced below the lesser of: (1) $10.00 per public share; or (2) such lesser amount per public share held in the trust account as
of the date of the liquidation of the trust account due to reductions in the value of the trust assets, in each case net of the amount
of interest which may be withdrawn to pay taxes, and our sponsor asserts that it is unable to satisfy its obligations or that it has no
indemnification obligations related to a particular claim, our independent directors would determine whether to take legal action against
our sponsor to enforce its indemnification obligations. While we currently expect that our independent directors would take legal action
on our behalf against our sponsor to enforce its indemnification obligations to us, it is possible that our independent directors in exercising
their business judgment may choose not to do so in certain instances. For example, the cost of such legal action may be deemed by the
independent directors to be too high relative to the amount recoverable or the independent directors may determine that a favorable outcome
is not likely. If our independent directors choose not to enforce these indemnification obligations, the amount of funds in the trust
account available for distribution to our public stockholders may be reduced below $10.00 per share.
Required Vote
Approval of the Charter Amendment proposal requires
the affirmative vote of holders of at least 65% of Concord’s common stock outstanding on the record date. If the Charter Amendment
proposal is not approved and Concord is unable to complete a business combination on or before December 10, 2022, it will be required
by its charter to (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but no more
than ten business days thereafter subject to lawfully available funds therefor, redeem 100% of the public shares, at a per-share price,
payable in cash, equal to the aggregate amount then on deposit in the trust account, including interest (which interest shall be net of
taxes payable, and less up to $100,000 of interest to pay dissolution expenses), divided by the number of then outstanding public shares,
which redemption will completely extinguish rights of the public stockholders, as stockholders (including the right to receive further
liquidating distributions, if any), subject to applicable law, and (iii) as promptly as reasonably possible following such redemption,
subject to the approval of the remaining stockholders and the Board in accordance with applicable law, liquidate and dissolve, subject
in each case to our obligations under Delaware law to provide for claims of creditors and the requirements of other applicable law. All
of Concord’s directors, executive officers and their affiliates are expected to vote any common stock owned by them in favor of
the Charter Amendment. On the record date, directors and executive officers of Concord and their affiliates beneficially owned and were
entitled to vote [•] shares of common stock representing approximately [•]% of Concord’s issued and outstanding common
stock.
Interests of Concord’s Directors and Officers
When you consider the recommendation of the Board,
you should keep in mind that Concord’s executive officers and members of the Board have interests that may be different from, or
in addition to, your interests as a stockholder. These interests include, among other things:
|
● |
If the Charter Amendment is not approved and we do not consummate a
business combination by December 10, 2022 as contemplated by our IPO prospectus and in accordance with our charter, the 6,030,289 shares
of common stock held by Concord officers, directors and affiliates, which were acquired prior to the IPO for an aggregate purchase price
of approximately $25,000, will be worthless (as the holders have waived liquidation rights with respect to such shares), as will the 510,289
private warrants that were acquired simultaneously with the IPO and over-allotment by our sponsor for an aggregate purchase price of $5,102,890,
which will expire. Such common stock and warrants had an aggregate market value of approximately $[•] based on the last sale price
of Concord’s common stock and warrants of $[•] and $[•], respectively, on NYSE on [•], 2022; |
|
● |
In connection with the IPO, our sponsor agreed that it will be
liable under certain circumstances to ensure that the proceeds in the trust account are not reduced by the claims of target businesses
or vendors or other entities that are owed money by Concord for services rendered, contracted for or products sold to the Concord; |
|
● |
All rights specified in Concord’s charter relating to the
right of officers and directors to be indemnified by Concord, and of Concord’s officers and directors to be exculpated from monetary
liability with respect to prior acts or omissions, will continue after a business combination. If the business combination is not approved
and Concord liquidates, Concord will not be able to perform its obligations to its officers and directors under those provisions; |
|
● |
None of Concord’s executive officers or directors has received any cash compensation for services rendered to Concord. All of the current members of Concord’s board of directors are expected to continue to serve as directors at least through the date of the special meeting and Bob Diamond, Concord’s chairman of the Board, is expected to continue to serve as a director following the consummation of the proposed Transaction and receive compensation thereafter; |
|
● |
Our sponsor has the ability to loan to Concord up to $350,000, which
was evidenced by an unsecured promissory note, which is payable without interest upon consummation of a business combination. In the event
that Concord does not complete an initial business combination, it may use a portion of the working capital held outside the trust account
to repay such loaned amount but no proceeds from the trust account may be used for such repayment. Accordingly, Concord will most likely
be unable to repay the loan if a business combination is not completed; |
|
● |
Concord has entered into an Administrative Services Agreement
with our sponsor, pursuant to which, Concord pays $10,000 per month for office space, administrative and support services. Upon the earlier
of completion of a business combination or liquidation, Concord will cease paying these monthly fees. Accordingly, our sponsor may receive
payments in excess of the 24 payments originally contemplated, if the Charter Amendment is implemented. |
The Board’s Reasons for the Charter Amendment Proposal and
Its Recommendation
As discussed below, after careful consideration
of all relevant factors, the Board has determined that the Charter Amendment proposal is fair to, and in the best interests of, Concord
and its stockholders. The Board has approved and declared advisable adoption of the Charter Amendment proposal, and recommends that you
vote “FOR” such adoption. The Board expresses no opinion as to whether you should redeem your public shares.
We are a Delaware company incorporated in August
2020 for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business
combination with one or more businesses. On December 10, 2020, we consummated an IPO of 27,600,000
units, including the issuance of 3,600,000 units as a result of the exercise in full of the underwriters’ over-allotment option,
at $10.00 per unit, generating gross proceeds of $276,000,000. Simultaneously with the closing of the offering, the Company consummated
the private placement of 510,289 units to the sponsor, and 241,711 units to CA Co-Investment, each at a price of $10.00 per private unit,
generating total proceeds of $7,520,000. Following the closing of the IPO, an aggregate of
$276,000,000 was held in the trust account.
Concord’s IPO prospectus and charter provide
that Concord has until December 10, 2022 to consummate a business combination. The proposed Transaction with Topco qualifies as an initial
business combination under Concord’s charter, but Concord will not be able to complete the Transaction by December 10, 2022. The
Charter Amendment is essential to allowing Concord more time to obtain approval for the Transaction at a special meeting of its stockholders
and consummate the Transaction prior to the Extended Date. Approval of the Charter Amendment is a condition to the implementation of the
Extension. Concord believes that given its expenditure of time, effort and money on the Transaction, circumstances warrant providing public
stockholders an opportunity to consider the proposed Transaction. The affirmative vote of the holders of at least 65% of all outstanding
shares of common stock is required to extend Concord’s corporate existence, except in connection with, and effective upon consummation
of, a business combination. Additionally, Concord’s IPO prospectus and charter provide for all public stockholders to have an opportunity
to redeem their public shares in the case Concord’s corporate existence is extended as described above. Because Concord continues
to believe that a business combination would be in the best interests of Concord’s stockholders, and because Concord will not be
able to consummate a business combination within the permitted time period, Concord has determined to seek stockholder approval to extend
the date by which Concord has to complete a business combination beyond December 10, 2022 to the Extended Date.
Concord is not asking you to vote on a business
combination at this time. If the Extension is implemented and you do not elect to redeem your public shares, you will retain the right
to vote on any proposed business combination when it is submitted to stockholders and the right to redeem your public shares for a pro
rata portion of the trust account in the event such business combination is approved and completed or the Company has not consummated
a business combination by the Extended Date.
The affirmative vote of the holders of at least
65% of all then outstanding shares of common stock is required to effect an amendment to Concord’s charter that would extend its
corporate existence beyond December 10, 2022, except in connection with, and effective upon consummation of, a business combination. Additionally,
Concord’s charter requires that all public stockholders have an opportunity to redeem their public shares in the case Concord’s
corporate existence is extended as described above. We believe that these charter provisions were included to protect Concord stockholders
from having to sustain their investments for an unreasonably long period, if Concord failed to find a suitable business combination in
the timeframe contemplated by the charter. We also believe, however, that given Concord’s expenditure of time, effort and money
on the proposed Transaction, circumstances warrant providing public stockholders an opportunity to consider the proposed Transaction,
inasmuch as Concord is also affording stockholders who wish to redeem their public shares the opportunity to do so, as required under
its charter. Accordingly, the Extension is consistent with Concord’s charter and IPO prospectus.
After careful consideration of all relevant factors,
Concord’s board of directors determined that the Charter Amendment is fair to and in the best interests of Concord and its stockholders.
The Board of Directors recommends that you vote
“FOR” the Charter Amendment proposal. The Board of Directors expresses no opinion as to whether you should redeem your public
shares.
THE ADJOURNMENT
PROPOSAL
The Adjournment Proposal, if adopted, will request
the chairman of the special meeting (who has agreed to act accordingly) to adjourn the special meeting to a later date or dates to permit
further solicitation of proxies. The Adjournment Proposal will only be presented to our stockholders in the event, based on the tabulated
votes, there are not sufficient votes at the time of the special meeting to approve the Charter Amendment proposal. If the Adjournment
Proposal is not approved by our stockholders, the chairman of the meeting will not exercise his ability to adjourn the special meeting
to a later date (which he would otherwise have under our Amended and Restated Certificate of Incorporation) in the event, based on the
tabulated votes, there are not sufficient votes at the time of the special meeting to approve any of the Charter Amendment proposal.
Required Vote
If a majority of the votes cast present in person
or by proxy and voting on the matter at the special meeting vote for the Adjournment Proposal, the chairman of the special meeting will
exercise his or her power to adjourn the meeting as set out above.
All of Concord’s directors, executive officers
and their affiliates are expected to vote any shares owned by them in favor of the Adjournment Proposal. On the record date, directors
and executive officers of Concord and their affiliates beneficially owned and were entitled to vote [●] shares of common stock representing
approximately [●]% of Concord’s issued and outstanding shares of common stock.
Recommendation of the Board
The Board recommends
that, if presented, you vote “FOR” the Adjournment Proposal.